DNLI Denali Therapeutics Inc.
Executive Summary
Mixed institutional activity in Denali Therapeutics for 2025-Q3: 3 large passive buyers (Morgan Stanley, UBS, BofA) added $27M in positions, led by UBS nearly doubling its stake to $29.2M, but 4 sellers—notably Norges Bank fully exiting a $55.2M position and T. Rowe Price trimming 30.6% of shares—removed ~$64.6M from the stock. The net selling pressure of ~$37.6M and the 100% exit by a sovereign wealth fund dominate the passive additions, but the cluster lacks conviction from active funds, muting the signal. Historical reports on DNLI have underperformed (0% win rate at T+20), suggesting limited trading-alpha capture on this ticker.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$37.6M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +28.8% | $24.5M | $6.2M |
| UBS | DOUBLED | +111.7% | $29.2M | $15.9M |
| BofA | ADD | +47.8% | $14.0M | $4.9M |
▼ Sellers (4)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| T. Rowe Price | TRIM | -30.6% | — | -$25.8K |
| Norges Bank | EXIT | -100% | $55.2M | -$55.2M |
| Citadel | TRIM | -44.9% | $17.5M | -$7.5M |
| RenTech | TRIM | -69.4% | $2.7M | -$1.9M |
Actionable Insight
The institutional cluster is dominated by passive flows (buyers) vs. one sovereign exit and quant trims (sellers), producing a net reduction. Without a clear active-fund catalyst, the signal is weak. Monitor for a same-quarter SC 13D or earnings-driven catalyst to explain the Norges exit; until then, the cluster is a neutral-to-modestly-bearish data point on sentiment without strong trading conviction. Given prior model underperformance on DNLI reports, treat the impact as low confidence.
Key Facts
- 3 passive mega-funds added $27.0M in new holdings; UBS doubled to $29.2M (+111.7%)
- 4 sellers reduced holdings by ~$64.6M; Norges Bank fully exited a $55.2M position
- Net aggregate movement: sellers outweighed buyers by ~$37.6M
- No active activist/event-driven fund participation — all buyers are passive; sellers include quant and sovereign
- Historical DNLI reports have 0% win rate T+20 (avg alpha -12.17% vs SPY), suggesting poor prior-model calibration on this ticker
Financial Impact
3 institutional buyers added $27.0M (new total $67.7M), while 4 sellers reduced by $64.6M; net outflow ~$37.6M
Risk Factors
- Norges Bank's 100% exit (sovereign account) signals institutional reluctance that may precede further unwinding by active managers
- 45-day 13F lag means positions may already be reversed; UBS's doubling could be stale
- Passive-only buying provides no evidence of active conviction; cluster has no activist or concentrated fund participation
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-DNLI-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $21.01 awaiting T+5 | awaiting T+5 | — | — |
|
May 21, 2026
22d ago
|
Press Release
| $18.64 $20.41 | ▼ −9.50% | ▼ −7.84% | — |
|
May 7, 2026
5w ago
|
Press Release
| $19.62 $19.39 | ▼ −1.17% | ▼ −2.64% | — |
|
Apr 3, 2026
10w ago
|
8-K
| $19.38 $19.42 | ▲ +0.21% | ▼ −3.93% | — |
|
Apr 3, 2026
10w ago
|
Press Release
| $19.38 $19.42 | ▲ +0.21% | ▼ −3.93% | — |
|
Mar 25, 2026
11w ago
|
Press Release
| $22.47 $19.68 | ▼ −12.42% | ▼ −12.17% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access